Peter Leary
Leary, Peter J., 1978-
VIAF ID: 313293338 ( Personal )
Permalink: http://viaf.org/viaf/313293338
Preferred Forms
-
100 1 _
‡a
Leary, Peter J.
‡d
1978-
-
100 1 _
‡a
Leary, Peter J.,
‡d
1978-
-
100 0 _
‡a
Peter Leary
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| Accuracy of Doppler blood pressure measurement in continuous-flow left ventricular assist device patients |
|
| BMPR2 Mutation Carriers: Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension Without Symptoms: Cautionary Tales? |
|
| Causality, Correlation, and Cardiac Disease: Does Smoking Cause Cardiac Hypertrophy and Diastolic Dysfunction? |
|
| Delayed pneumothorax after bronchoscopy in a lung transplant patient. |
|
| The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease |
|
| Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension. |
|
| H2-receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program. |
|
| Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study |
|
| Hole in one |
|
| Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile |
|
| Maternal, perinatal, and postneonatal outcomes in women with chronic heart disease in Washington State |
|
| Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice |
|
| Pulmonary Arterial Elastance and INTERMACS-Defined Right Heart Failure Following Left Ventricular Assist Device |
|
| Pulmonary Hypertension: Good Intentions, But a Questionable Approach |
|
| Pulmonary Hypertension in Congenital Heart Disease: Beyond Eisenmenger Syndrome. |
|
| Randomized controlled trials: a solid platform for observational research. |
|
| Reply: Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis? |
|
| Reply: Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure? |
|
| Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension |
|
| Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis. |
|
| A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with PAH or CTEPH and Impact on the Process of Care |
|
| A Tale of Two Hearts: Patients with Decompensated Right Heart Failure in the Intensive Care Unit. |
|
| Three-dimensional analysis of right ventricular shape and function in pulmonary hypertension |
|
| Traffic-related air pollution and the right ventricle. The multi-ethnic study of atherosclerosis |
|
| A very close call. |
|
| Volume Overload: Prevalence, Risk Factors, and Functional Outcome in Survivors of Septic Shock |
|
| Von Willebrand factor and the right ventricle (the MESA-Right Ventricle Study) |
|
| What's in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension. |
|
| Which Needle in Which Haystack? Multisystem Care for Pulmonary Hypertension Patients |
|
